Evidence map›Paper›PMID 37779543›Full record

ArticleThe journal of allergy and clinical immunology. Global2022

Determination of ragweed allergen Amb a 1 distribution in aerosols using ELISA and immunogold scanning electron microscopy.

Manfred Nachtnebel, Bernadette Führer, Gabriele Ettenberger-Bornberg, Johannes Mertl, Lilian Kaufmann, Hartmuth Schroettner, Johannes Rattenberger

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Manfred NachtnebelGraz Centre for Electron Microscopy (ZFE), Steyrergasse, Graz, Austria.
Bernadette FührerÖsterreichisches Forschungsinstitut für Chemie und Technik (OFI), Franz-Grill-Straße 5/Objekt 213, Wien, Austria.
Gabriele Ettenberger-BornbergÖsterreichisches Forschungsinstitut für Chemie und Technik (OFI), Franz-Grill-Straße 5/Objekt 213, Wien, Austria.
Johannes MertlÖsterreichisches Forschungsinstitut für Chemie und Technik (OFI), Franz-Grill-Straße 5/Objekt 213, Wien, Austria.
Lilian KaufmannÖsterreichisches Forschungsinstitut für Chemie und Technik (OFI), Franz-Grill-Straße 5/Objekt 213, Wien, Austria.
Hartmuth SchroettnerGraz Centre for Electron Microscopy (ZFE), Steyrergasse, Graz, Austria.
Johannes RattenbergerGraz Centre for Electron Microscopy (ZFE), Steyrergasse, Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ragweed as an invasive species in Europe has become more important for allergy sufferers in the last decade. Because pollen fractions can be found in the respirable fraction of aerosols, they can generate severe disease progressions. Objective: To obtain information about the concentration and distribution of 1 of the main ragweed allergens Methods: Standard fine dust filters used for air quality monitoring were analyzed via ELISA and immunogold scanning electron microscopy. Results: Via ELISA it was possible to show that already at pollen season start in August a recognizably high Conclusions: It was possible to show that reliable results can be obtained from ELISA and immunogold scanning electron microscopy directly applied on filters that are used in air quality monitoring sites. By adaptation of the used protocols, it should be possible to obtain respective information about further allergens.

Indexed as

air quality monitoringAmb a 1 allergenELISAfine dust filtersimmunogold scanning electron microscopyseasonal trend

Identifiers

PMID37779543
PMCPMC10509994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.